I find this PR interesting in that I was under the impression that IPIX really does not have the financial ability to continue to fund trials (I assumed the recent Phase I for oral pill was likely the last one they could afford). On top of that, they sent a batch of Brilacidin to be tested for COVID19 which was likely on their own dime (maybe?) and there were material transfer contracts to execute which likely required legal review prior to moving forward (everything has a cost). If they have a different funding source, we should hear about it relatively soon. It makes me wonder whether this is Leo's way of letting us know that a deal is about to be signed?